183 related articles for article (PubMed ID: 28581513)
1. KIF26B, a novel oncogene, promotes proliferation and metastasis by activating the VEGF pathway in gastric cancer.
Zhang H; Ma RR; Wang XJ; Su ZX; Chen X; Shi DB; Guo XY; Liu HT; Gao P
Oncogene; 2017 Oct; 36(40):5609-5619. PubMed ID: 28581513
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.
Xu M; Qin S; Cao F; Ding S; Li M
Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929
[TBL] [Abstract][Full Text] [Related]
3. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
[TBL] [Abstract][Full Text] [Related]
4. Upregulated β-arrestin1 predicts poor prognosis and promotes metastasis via AKT/ERK signaling pathway in gastric cancer.
Xu T; Shen G; Cheng M; Wu X; Xu Y; Hu S
Pathol Res Pract; 2020 Dec; 216(12):153262. PubMed ID: 33129195
[TBL] [Abstract][Full Text] [Related]
5. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
[TBL] [Abstract][Full Text] [Related]
6. miR-664a-3p functions as an oncogene by targeting Hippo pathway in the development of gastric cancer.
Wang L; Li B; Zhang L; Li Q; He Z; Zhang X; Huang X; Xu Z; Xia Y; Zhang Q; Li Q; Xu J; Sun G; Xu Z
Cell Prolif; 2019 May; 52(3):e12567. PubMed ID: 30883979
[TBL] [Abstract][Full Text] [Related]
7. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
Li J; Zou X
Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
[TBL] [Abstract][Full Text] [Related]
8. miR-135a promotes gastric cancer progression and resistance to oxaliplatin.
Yan LH; Chen ZN; Li-Li ; Chen J; Wei WE; Mo XW; Qin YZ; Lin Y; Chen JS
Oncotarget; 2016 Oct; 7(43):70699-70714. PubMed ID: 27683111
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-26b inhibits tumor metastasis by targeting the KPNA2/c-jun pathway in human gastric cancer.
Tsai MM; Huang HW; Wang CS; Lee KF; Tsai CY; Lu PH; Chi HC; Lin YH; Kuo LM; Lin KH
Oncotarget; 2016 Jun; 7(26):39511-39526. PubMed ID: 27078844
[TBL] [Abstract][Full Text] [Related]
10. miR-93-5p/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway.
Ma DH; Li BS; Liu JJ; Xiao YF; Yong X; Wang SM; Wu YY; Zhu HB; Wang DX; Yang SM
Cancer Lett; 2017 Nov; 408():23-32. PubMed ID: 28842285
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of miRNA‑301a‑3p promotes tumor progression in gastric cancer by suppressing NKRF and activating NF‑κB signaling.
Xu X; Xia Y; Ma J; Li W; Niu N; Li X; Tao H; Xu J; He X
Int J Oncol; 2020 Aug; 57(2):522-532. PubMed ID: 32468020
[TBL] [Abstract][Full Text] [Related]
12. High expression of TCF12 contributes to gastric cancer development via being target regulated by miR-183 and activating PI3K/AKT pathway.
Wang X; Gao S; Xie F; Li W; Li M; Yan N; Gao T; Fang L
J Cell Biochem; 2019 Aug; 120(8):13903-13911. PubMed ID: 30982999
[TBL] [Abstract][Full Text] [Related]
13. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
[TBL] [Abstract][Full Text] [Related]
14. CircRBMS3 promotes gastric cancer tumorigenesis by regulating miR-153-SNAI1 axis.
Li G; Xue M; Yang F; Jin Y; Fan Y; Li W
J Cell Physiol; 2019 Mar; 234(3):3020-3028. PubMed ID: 30132886
[TBL] [Abstract][Full Text] [Related]
15. Aberrantly expressed miR-188-5p promotes gastric cancer metastasis by activating Wnt/β-catenin signaling.
Li Y; Yan X; Shi J; He Y; Xu J; Lin L; Chen W; Lin X; Lin X
BMC Cancer; 2019 May; 19(1):505. PubMed ID: 31138169
[TBL] [Abstract][Full Text] [Related]
16. RABEX-5 is upregulated and plays an oncogenic role in gastric cancer development by activating the VEGF signaling pathway.
Wang S; Lu A; Chen X; Wei L; Ding J
PLoS One; 2014; 9(11):e113891. PubMed ID: 25427001
[TBL] [Abstract][Full Text] [Related]
17. sMicroRNA-28-5p acts as a metastasis suppressor in gastric cancer by targeting Nrf2.
Yue CF; Li LS; Ai L; Deng JK; Guo YM
Exp Cell Res; 2021 May; 402(2):112553. PubMed ID: 33737068
[TBL] [Abstract][Full Text] [Related]
18. KIF26B promotes cell proliferation and migration through the FGF2/ERK signaling pathway in breast cancer.
Teng Y; Guo B; Mu X; Liu S
Biomed Pharmacother; 2018 Dec; 108():766-773. PubMed ID: 30248545
[TBL] [Abstract][Full Text] [Related]
19. Sex determining region Y-box 12 (SOX12) promotes gastric cancer metastasis by upregulating MMP7 and IGF1.
Du F; Feng W; Chen S; Wu S; Cao T; Yuan T; Tian D; Nie Y; Wu K; Fan D; Xia L
Cancer Lett; 2019 Jun; 452():103-118. PubMed ID: 30922917
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of MiR-1297 predicts poor prognosis and enhances gastric cancer cell growth by targeting CREB1.
Gao W; Cao Y; Guo P; Bao X; Zhu H; Zheng J; Yao C; Chen D; Yu S; Chen B; Zhou S; Pang D; Chen W
Biomed Pharmacother; 2018 Sep; 105():413-419. PubMed ID: 29870889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
